SCHEMBL30765178

SCHEMBL30765178

C[C@@H]1CN(C(=O)c2ccc(-c3cc4nccc(-c5ccnc(C(C)(C)O)c5)c4o3)cc2)C[C@@H](C)O1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
NAMPT P43490 1/20 0.38
CRHBP P24387 3/20 0.38
CRHR2 Q13324 3/20 0.38
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.35
JAK2 O60674 1/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD11B1 P28845 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27263347 1.00 NPC1 (0.43) NPC1ALDH1A1HPGDHSD17B10NPSR1
SCHEMBL30765379 1.00 NPC1 (0.43) NPC1ALDH1A1HPGDHSD17B10NPSR1
SCHEMBL27263346 1.00 NPC1 (0.43) NPC1ALDH1A1HPGDHSD17B10NPSR1
SCHEMBL30765285 0.91 GLRA1 (0.39) NPC1NAMPT
SCHEMBL30765202 0.91 GLRA1 (0.39) NPC1NAMPT
SCHEMBL30765255 0.91 GLRA1 (0.39) NPC1NAMPT
SCHEMBL32672625 0.88 NPC1 (0.42) NPC1ALDH1A1HPGDHSD17B10NPSR1
SCHEMBL32672563 0.88 NPC1 (0.42) NPC1ALDH1A1HPGDHSD17B10NPSR1
SCHEMBL32672657 0.88 NPC1 (0.42) NPC1ALDH1A1HPGDHSD17B10NPSR1
SCHEMBL27267083 0.88 NPC1 (0.42) NPC1ALDH1A1HPGDHSD17B10NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024033280-A1 FUROPYRIDIN AND FUROPYRIMIDIN, INHIBITORS OF PI4K, FOR USE IN THE TREATMENT OF PARASITE INFECTION AND MALARIA MERCK PATENT GMBH (DE) 2024-02-15 WO disclosed